TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
Prif Awdur: | Feneberg, E |
---|---|
Awduron Eraill: | Turner, M |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2019
|
Pynciau: |
Eitemau Tebyg
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
gan: Rachel H. Tan, et al.
Cyhoeddwyd: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
gan: Yuhan Wu, et al.
Cyhoeddwyd: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
gan: Piotr Włodarczyk, et al.
Cyhoeddwyd: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
gan: Joanna Iłżecka
Cyhoeddwyd: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
gan: Joanna Iłżecka
Cyhoeddwyd: (2017-12-01)